These findings revealed distinct roles of SPP1+/SLC11A1+ and SPP1-/SLC11A1- macrophages in CRC, with SPP1+/SLC11A1+ macrophages emerging as a potential new therapeutic target for CRC treatment. The gene discussed is SPP1; the disease is colorectal carcinoma.